Clinical Trial Update: Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating decitabine in combination with mBU/CY for high-risk acute leukemia with minimal residual disease before hematopoietic stem c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Leukemia Myeloid Acute
• Leukemia Relapse
• Stem Cell Transplantation Complications

Drugs mentioned

• CY (cyclophosphamide)
• Decitabine (Decitabine)
• mBU (busulfan)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Stem Cell Transplant Complications, Leukemia, Myeloid, Acute | Phase 2, Phase 3 | Status: RECRUITING